Olympus Announces FDA Clearance of RenaFlex™, Its First Single-use Flexible Ureteroscope
Posted:
Olympus Corporation single-use flexible ureteroscopy system, RenaFlex™, has received clearance from the U.S. Food and Drug Administration (FDA) and will soon be available in the United States.
This product assists in the diagnosis and treatment of urological conditions such as #Urolithiasis.
The Bacillus Calmette-Guérin (BCG) vaccine prevents severe forms of tuberculosis (TB) and is the world’s most widely used vaccine, as well as the oldest vaccine still in use.
Read more here.
Cigna's Evernorth is investing $100 million through 2028 in specialty pharmacy care.
The AI program called Pharmacy Forward is expected to generate approximately $400 million in value by the end of 2028, according to Evernorth.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us